Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT03278899
A Study to Prospectively Assess Disease Progression in Male Children With X-ALD
Phase: N/A
Role: Lead Sponsor
Start: Feb 16, 2018
Completion: Jun 1, 2021
NCT03196765
Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
Phase: Phase 1/2
Start: Aug 31, 2018
Completion: Dec 1, 2020